Premier Path Wealth Partners’s Gilead Sciences GILD Stock Holding History

Premier Path Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.04M	Buy	16,156 +340	+2%	+$44.8K	0.23%	96
2026 Q1	$2.2M	Buy	15,816 +2,535	+19%	+$355K	0.29%	81
2025 Q4	$1.63M	Buy	13,281 +2,194	+20%	+$267K	0.21%	101
2025 Q3	$1.23M	Buy	11,087 +1,318	+13%	+$150K	0.16%	140
2025 Q2	$1.08M	Buy	9,769 +905	+10%	+$96.3K	0.15%	164
2025 Q1	$993K	Buy	8,864 +812	+10%	+$83.8K	0.15%	160
2024 Q4	$744K	Buy	8,052 +3,797	+89%	+$342K	0.11%	184
2024 Q3	$357K	Buy	4,255 +926	+28%	+$70.7K	0.06%	277
2024 Q2	$228K	Sell	3,329 -598	-15%	-$39.9K	0.04%	337
2024 Q1	$288K	Sell	3,927 -995	-20%	-$76.5K	0.05%	281
2023 Q4	$399K	Buy	+4,922	New	+$383K	0.09%	217

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Premier Path Wealth Partners's GILD Position: Q2 2026 in Review

Premier Path Wealth Partners increased its Gilead Sciences (GILD) stake by 2.1% in Q2 2026, buying an estimated $44.8K and bringing the position to 16,156 shares worth $2.04M. The position accounts for 0.23% of the portfolio, ranked #96.

Premier Path Wealth Partners first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.2M in Q1 2026. 911 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Premier Path Wealth Partners held 16,156 shares of Gilead Sciences worth $2.04M as of Q2 2026.
Premier Path Wealth Partners bought 340 Gilead Sciences shares in Q2 2026, an estimated $44.8K.
Gilead Sciences made up 0.23% of Premier Path Wealth Partners's portfolio in Q2 2026, its #96 holding.
Premier Path Wealth Partners first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
Premier Path Wealth Partners's Gilead Sciences position peaked at $2.2M in Q1 2026.
911 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Premier Path Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.